CUBN and glioblastoma: Additionally, we observed B cells in regions near BVax-derived, Ig-recognized antigens (Supplemental Figure 10), and peritumoral brain had low expression of these ECM proteins compared the GBM microenvironment itself (Supplemental Figure 11), indicating therapeutic potential for BVax-derived Igs.